NYSE:SYK - Stryker Stock Price, Price Target & More

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker declared a quarterly dividend on Wednesday, February 7th. Investors of record on Thursday, March 29th will be given a dividend of $0.47 per share on Monday, April 30th. This represents a $1.88 annualized dividend and a dividend yield of 1.14%. The ex-dividend date is Wednesday, March 28th. View Stryker's Dividend History.

Stryker Co. (NYSE:SYK) released its quarterly earnings results on Tuesday, January, 30th. The medical technology company reported $1.96 EPS for the quarter, beating the consensus estimate of $1.95 by $0.01. The medical technology company earned $3.47 billion during the quarter, compared to analyst estimates of $3.42 billion. Stryker had a net margin of 8.20% and a return on equity of 24.56%. Stryker's revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.78 EPS. View Stryker's Earnings History.

Stryker is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for Stryker.

Stryker updated its FY18 earnings guidance on Tuesday, January, 30th. The company provided earnings per share guidance of $7.07-7.17 for the period, compared to the Thomson Reuters consensus estimate of $7.13. Stryker also updated its Q1 guidance to $1.57-1.62 EPS.

24 brokers have issued 12 month price objectives for Stryker's stock. Their forecasts range from $129.00 to $186.00. On average, they expect Stryker's share price to reach $164.7143 in the next twelve months. View Analyst Ratings for Stryker.

Stryker saw a decrease in short interest in March. As of March 29th, there was short interest totalling 5,374,898 shares, a decrease of 36.3% from the March 15th total of 8,444,053 shares. Based on an average trading volume of 1,188,121 shares, the days-to-cover ratio is presently 4.5 days. Approximately 1.5% of the company's stock are sold short.

Some companies that are related to Stryker include 3M (MMM), Becton Dickinson (BDX), Fresenius (FSNUY), Boston Scientific (BSX), Baxter International (BAX), ResMed (RMD), Abiomed (ABMD), Teleflex (TFX), Dexcom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Globus Medical (GMED), Cantel Medical (CMD) and Penumbra (PEN).

Media headlines about SYK stock have been trending positive recently, Accern Sentiment Analysis reports. The research firm identifies positive and negative press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Stryker earned a coverage optimism score of 0.25 on Accern's scale. They also assigned news coverage about the medical technology company an impact score of 46.46 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $164.71.

Stryker has a market capitalization of $61.53 billion and generates $12.44 billion in revenue each year. The medical technology company earns $1.02 billion in net income (profit) each year or $6.49 on an earnings per share basis. Stryker employs 33,000 workers across the globe.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]